Involvement of TRAIL and its receptors in viral hepatitis
- PMID: 12475902
- DOI: 10.1096/fj.02-0537fje
Involvement of TRAIL and its receptors in viral hepatitis
Abstract
Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) is able to kill a broad spectrum of tumor cells but appears to be nontoxic to most normal cells. Because there are conflicting data about the hepatotoxicity of TRAIL, we investigated the physiological function of TRAIL and its receptors in the liver. Hepatocytes are sensitive for FasL- and TRAIL-mediated apoptosis in vitro, but TRAIL induces no apoptosis in healthy livers in vivo. Using mouse models of adenoviral hepatitis and livers of patients with hepatitis infection, we could demonstrate that apoptosis in virally infected hepatocytes is mediated by TRAIL receptor DR5 and TRAIL. In contrast to FasL, TRAIL-mediated apoptosis of hepatocytes in vivo is triggered through viral infection. The TRAIL receptor/ligand system enables the organisms to specifically kill virus-infected hepatocytes, whereas normal uninfected hepatocytes in vivo are resistant to TRAIL-mediated apoptosis. Overexpression of TRAIL in the liver after viral infection is not dependent on lymphocytes, natural killer, or Kupffer cells, which indicates that the TRAIL receptor/ligand system is a paracrine mechanism of hepatocytes against virally infected cells. Our results suggest that TRAIL might be used not only for cancer therapy but also for therapy of patients with viral hepatitis to selectively eliminate infected hepatocytes and limit viral replication.
Similar articles
-
Tumour necrosis factor related apoptosis inducing ligand (TRAIL) induces hepatic steatosis in viral hepatitis and after alcohol intake.Gut. 2005 Nov;54(11):1590-6. doi: 10.1136/gut.2004.056929. Gut. 2005. PMID: 16227360 Free PMC article.
-
Thyroid carcinoma cells are resistant to FAS-mediated apoptosis but sensitive to tumor necrosis factor-related apoptosis-inducing ligand.Cancer Res. 2000 Aug 1;60(15):4122-9. Cancer Res. 2000. PMID: 10945619
-
NFkappaB-mediated upregulation of bcl-xl restrains TRAIL-mediated apoptosis in murine viral hepatitis.Hepatology. 2005 Feb;41(2):280-8. doi: 10.1002/hep.20566. Hepatology. 2005. PMID: 15660391
-
TRAIL and apoptosis induction by TNF-family death receptors.Oncogene. 2003 Nov 24;22(53):8628-33. doi: 10.1038/sj.onc.1207232. Oncogene. 2003. PMID: 14634624 Review.
-
TRAIL: a molecule with multiple receptors and control mechanisms.Curr Opin Immunol. 1998 Oct;10(5):559-63. doi: 10.1016/s0952-7915(98)80224-0. Curr Opin Immunol. 1998. PMID: 9794836 Review.
Cited by
-
TRAIL and its receptors as targets for cancer therapy.Cancer Sci. 2004 Oct;95(10):777-83. doi: 10.1111/j.1349-7006.2004.tb02181.x. Cancer Sci. 2004. PMID: 15504243 Free PMC article. Review.
-
Viral Persistence and Chronicity in Hepatitis C Virus Infection: Role of T-Cell Apoptosis, Senescence and Exhaustion.Cells. 2018 Oct 12;7(10):165. doi: 10.3390/cells7100165. Cells. 2018. PMID: 30322028 Free PMC article. Review.
-
The Receptor Interacting Protein Kinases in the Liver.Semin Liver Dis. 2018 Feb;38(1):73-86. doi: 10.1055/s-0038-1629924. Epub 2018 Feb 22. Semin Liver Dis. 2018. PMID: 29471568 Free PMC article. Review.
-
Apoptosis in animal models of virus-induced disease.Nat Rev Microbiol. 2009 Feb;7(2):144-55. doi: 10.1038/nrmicro2071. Nat Rev Microbiol. 2009. PMID: 19148180 Free PMC article. Review.
-
The role of innate immunity in HBV infection.Semin Immunopathol. 2013 Jan;35(1):23-38. doi: 10.1007/s00281-012-0331-y. Epub 2012 Jul 20. Semin Immunopathol. 2013. PMID: 22814721 Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
